Module I
The Venetian & Palazzo · Las Vegas, Nevada
$2,250 allied health · $2,750 physician · 3 days
Peptide therapies are increasingly playing a significant role in disease state management, performance health and anti-aging strategies. In clinical practices across the globe, peptide therapies are being used to care for cancer, infectious diseases, metabolic disorders, injuries, aesthetic medicine and much more.
The Peptide Therapy Certification program presented in 2 modules, highlights this most relevant and applicable therapy in medicine. Participants can expect to gain extensive knowledge in legal considerations, strength of evidence and clinical applications to utilize on Monday morning.
Featuring world-class clinicians and researchers, the modules will allow you to further your knowledge in the emerging field of peptides and regenerative medicine and adopting this modality into your clinical practices.
International Peptide Society Membership required for certification. Please learn more here or talk with your A4M Educational Advisor.
Regulatory
The landscape is moving in peptides' favor — and reading it is a clinical skill.
2026 brought real movement. In April, FDA removed twelve peptides from Category 2 of the 503A bulks list — a procedural step, not a safety clearance and not permission to compound. In July, its advisory committee recommended six of seven nominated substances for the Bulks List, against FDA staff recommendations.
Rulemaking takes time, and each peptide has its own standing. That's why regulatory literacy is taught alongside the clinical content here, not bolted on. You'll leave able to determine where any peptide stands, vet a compounding pharmacy, document appropriately, and explain it all to a patient who read something different online.
Curriculum
Module I addresses the peptides your patients are actually asking about, including the twelve at the center of FDA's 2026 reclassification.
BPC-157: Promotes healing, angiogenesis, and reduces inflammation; used for GI repair, tissue regeneration, and nervous system recovery.
Thymosin Beta-4 (TB4): Supports cell migration, wound healing, neuroregeneration, and tissue remodeling.
KPV (Lysine-Proline-Valine): Tripeptide with anti-inflammatory effects; supports gut integrity, wound healing, and mast cell stabilization.
RGN-259: A TB4-derived peptide under study for treating neurotrophic keratitis.
VIP (Vasoactive Intestinal Peptide): Modulates neuroimmune function, reduces inflammation, and supports circadian rhythm; used in Chronic Inflammatory Response Syndrome (CIRS).
Selank: Anxiolytic and nootropic; enhances cognition and mood.
PE-22-28: A spadin analog with antidepressant and neurogenic effects.
PT-141 (Bremelanotide): A melanocortin receptor agonist with mood and sexual function benefits.
CJC-1295/Ipamorelin: Stimulate growth hormone release; used for sleep, recovery, muscle growth, and cognition.
Sermorelin: GHRH analog for promoting natural GH/IGF-1 production; anti-aging and body composition.
Tesamorelin: GHRH analog used to reduce visceral fat and support cognitive performance and liver health in lipodystrophy and NAFLD.
GHRH / ALRN-5281: Peptides targeting GH axis; related to insulin sensitivity, thymic support, and oxidative stress control.
Ghrelin / Macimorelin: Appetite-stimulating peptides; Macimorelin is a ghrelin receptor agonist used for GH testing and potential in cachexia.
MOTS-c: Mitochondrial-derived peptide; boosts insulin sensitivity and supports metabolic health.
Nicotinamide Riboside (NR): NAD+ precursor enhancing mitochondrial function and cognitive resilience (not a peptide per se, but often used in peptide protocols).
Larazotide (AT-1001): Regulates tight junctions for intestinal permeability and is used in leaky gut, celiac disease, and autoimmune conditions.
GLP-1 agonists (Semaglutide, Tirzepatide, Liraglutide, Dulaglutide, Exenatide, Lixisenatide): Regulate blood sugar, reduce weight, and exhibit neuroprotective effects. Tirzepatide acts on dual GLP-1/GIP pathways.
Thymosin Alpha-1 (TA1): Boosts immune function; effective in viral infections, immune aging, and chronic inflammation.
Low Dose Naltrexone (LDN): Though not a peptide, it is frequently co-administered in peptide protocols for managing autoimmunity and chronic inflammation.
SPMs (Specialized Pro-Resolving Mediators): While technically not peptides, included for their overlapping use in inflammation resolution.
Wheat-Bran Peptides (LRP & LQP): Leucine-rich; studied for NASH and oxidative stress, AMPK activation, and mitochondrial function.
IRW Peptide: Ovotransferrin-derived; anti-inflammatory, supports PGC1α and mitochondrial metabolism.
TUDCA: Bile acid derivative often used with peptides in neurodegenerative and metabolic protocols.
Eight focus areas mapping each peptide to the clinical use it's reached for.
Tissue repair
Neurocognitive health
GH axis & recovery
Energy & metabolism
Gut/barrier function
Metabolic regulation
Immune modulation
Mitochondrial support
Faculty
Ten physicians, pharmacists and regulatory specialists who prescribe, compound and defend peptide therapy in their own practices.
Each session is taught by the person doing that work, from FDA compliance and sterile manufacturing to metabolic and regenerative protocols.
Tyler Chamberlain, PharmD, FAPC
Compounding pharmacist · regulatory compliance
A Purdue-trained compounding pharmacist with experience as Pharmacist in Charge and Chief of Regulations and Compliance, specializing in sterile and nonsterile compounding and quality assurance.
Certified in Sterility Assurance through PCCA and licensed in multiple states; works on SOPs, hazardous drug compounding and FDA, DEA and state compliance.
Gordon Crozier, DO
Medical Director, Crozier Clinic · A4M lead educator
A pioneer of genetics-based integrative medicine and Medical Director of Crozier Clinic in Orlando. Clinical faculty at the University of Kentucky, lead educator and curriculum developer for A4M, and a steering committee member of the International Peptide Society — he has trained over 250 centers nationwide in peptide therapy.
Lectures nationally on Lyme disease, mold-related illness, peptide science and glutathione; author of Healing One Cell at a Time, Ticked Off and Heal Your Cells.
Marisol Duque, MD
Integrative & bio-regenerative medicine
A medical surgeon with more than 18 years caring for patients across Latin America and Europe, specializing in integrative and bio-regenerative medicine, tissue regeneration, longevity, homotoxicology, neural therapy, and cardiovascular health.
Has treated over 10,000 patients and pioneered a regeneration technique that mimics the body’s own capacity to heal.
Abid Husain, MD, FACC, ABAARM
Cardiologist · preventive & metabolic cardiology
A board-certified cardiologist with more than two decades of practice in Colorado and Nevada, focused on advanced lipid disorders, atherosclerosis and long-term cardiovascular risk reduction.
Completed A4M’s Fellowship in Anti-Aging, Integrative and Metabolic Medicine and lectures on the cardiovascular case for metabolic and peptide therapies.
James LaValle, RPh, CCN
Clinical pharmacist · integrative & precision medicine
A clinical pharmacist and internationally recognized expert in integrative and precision medicine, with over three decades spent bridging pharmacology, nutrition and metabolic science to build individualized treatment protocols.
Author and educator on peptide therapy, hormone optimization and precision supplementation; has trained thousands of clinicians nationwide.
Kathleen O’Neil-Smith, MD, FAARM
Functional, integrative & regenerative internal medicine
A magna cum laude graduate of Boston University School of Medicine, with postgraduate training at Massachusetts General Hospital and Brigham and Women’s Hospital. Moved into functional and regenerative medicine in 2008.
An international thought leader in regenerative and peptide therapies who teaches worldwide; former member and coach of the US Women’s National Rowing Team.
Lee Rosebush, PharmD, JD, MBA
Partner, BakerHostetler · FDA & compounding law
A regulatory and patent attorney who previously worked as a registered pharmacist, now leading BakerHostetler’s pharmacy and reimbursement team and co-leading its FDA practice.
Speaks and writes widely on the Drug Quality and Security Act and FDA regulation of pharmacy compounding, with deep experience in 503A and 503B matters.
Erika Schwartz, MD
Founder, Evolved Science · A4M faculty
Trained in internal medicine and critical care at NYU, SUNY Downstate and Kings County Hospital, and became Director of Emergency Medicine at a New York trauma center at 28.
A leading voice in bioidentical hormone therapy, prevention and patient advocacy; best-selling author and host of A4M’s Redefining Medicine podcast.
Melissa Stefko, MBA, MS, Bac, ASQ, CQA
SVP Regulatory, Wells Pharmacy Network
Began her career as a microbiologist and has worked in quality assurance and quality control across the pharmaceutical industry since 2008, now leading regulatory strategy for a national compounding provider.
Holds an MBA, an MS in Biotechnology and a Regulatory Affairs Certificate; ASQ-certified Quality Auditor and board member of the Alliance for Pharmacy Compounding.
Elizabeth Yurth, MD, FAARFM, ABAARM
Medical Director, Boulder Longevity Institute
A nonsurgical musculoskeletal specialist with fellowship training in spine and sports medicine; former team physician for Stanford and Santa Clara University.
ABAARM board certified with FAARM and FAARFM fellowships, plus advanced training in epigenetic and human potential medicine and certification in peptide therapy.
7:30–8:30 am
James LaValle, RPh, CCN, MT, DHM, DHPh
8:30–10:00 am
Don’t miss
Melissa Stefko, MBA, MS, Bac, ASQ, CQA
10:00–10:30 am
Break
10:30 am–12:00 pm
Tyler Chamberlain, PharmD
12:00–1:30 pm
Lunch sponsored by Thesis Pharmacy
Kris Wusterhausen, DO
1:30–2:00 pm
Tyler Chamberlain, PharmD
2:00–3:00 pm
Erika Schwartz, MD
3:00–3:30 pm
Break
3:30–5:00 pm
James LaValle, RPh, CCN, MT, DHM, DHPh
5:00–6:00 pm
Elizabeth Yurth, MD
6:00 pm
Close of session
7:30–10:00 am
Don’t miss
Gordon Crozier, DO
10:00–10:30 am
Break
10:30 am–12:00 pm
James LaValle, RPh, CCN, MT, DHM, DHPh
12:00–1:30 pm
Lunch
1:30–2:30 pm
Elizabeth Yurth, MD
2:30–3:30 pm
James LaValle, RPh, CCN, MT, DHM, DHPh
3:30–4:00 pm
Break
4:00–5:00 pm
Abid Husain, MD
5:00–6:00 pm
James LaValle, RPh, CCN, MT, DHM, DHPh
6:00 pm
Close of session
7:30–8:30 am
Don’t miss
Lee Rosebush, PharmD, JD, MBA
8:30–10:00 am
Kathleen O’Neil-Smith, MD
10:00–10:30 am
Break
10:30–11:30 am
Kathleen O’Neil-Smith, MD
11:30 am–12:30 pm
Marisol Duque, MD
12:30–1:30 pm
Lunch
1:30–2:30 pm
Marisol Duque, MD
2:30–3:30 pm
Kathleen O’Neil-Smith, MD
3:30–4:00 pm
Break
4:00–5:00 pm
Faculty panel co-led by J. LaValle & E. Yurth
5:00 pm
Close of session
Draft agenda. Times and faculty subject to change.
Stay
Your home base for the three days — at the center of the Strip, steps from every session.
3355 S. Las Vegas Blvd · Las Vegas, NV 89109
A one night's deposit is due at the time of booking. The cancellation window is 30 days prior to arrival. Reservations canceled within 30 days of arrival forfeit the one-night deposit.
